Scott Leff's Insider Trades & SAST Disclosures
Scott Leff's most recent trade in Myriad Genetics, Inc. was a trade of 72,165 Common Stock done . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Scott Leff.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | Scott J. Leffler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 72,165 | 224,610 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Scott J. Leffler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.07 per share. | 13 Mar 2025 | 6,217 | 218,393 (0%) | 0% | 10.1 | 62,605 | Common Stock |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.25 per share. | 04 Mar 2025 | 539 | 13,945 (0%) | 0% | 130.3 | 70,205 | Common Stock |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 1,619 | 14,484 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.46 per share. | 02 Mar 2025 | 1,347 | 12,865 (0%) | 0% | 131.5 | 177,077 | Common Stock |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,631 | 14,967 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.49 per share. | 20 Feb 2025 | 755 | 14,212 (0%) | 0% | 126.5 | 95,500 | Common Stock |
| Myriad Genetics, Inc. | Scott J. Leffler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.54 per share. | 29 Jan 2025 | 12,230 | 152,445 (0%) | 0% | 12.5 | 153,364 | Common Stock |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 5,536 | 0 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Sale of securities on an exchange or to another person at price $ 132.66 per share. | 05 Nov 2024 | 5,536 | 13,336 (0%) | 0% | 132.7 | 734,406 | Common Stock |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.68 per share. | 05 Nov 2024 | 5,536 | 18,872 (0%) | 0% | 61.7 | 341,460 | Common Stock |
| Myriad Genetics, Inc. | Scott J. Leffler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 46,905 | 164,675 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Scott J. Leffler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 46,095 | 163,865 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 3,718 | 13,336 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Scott D. Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.22 per share. | 02 Mar 2024 | 386 | 9,618 (0%) | 0% | 93.2 | 35,983 | Common Stock |
| Myriad Genetics, Inc. | J. Scott Leffler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 117,770 | 117,770 (0%) | 0% | 0 | Common Stock | |
| Clover Health Investments ... | Scott Leffler J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.98 per share. | 25 Jan 2024 | 83,538 | 4,857,303 | - | 1.0 | 81,867 | Class A Common Stock |
| Clover Health Investments ... | Scott J. Leffler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.09 per share. | 25 Jul 2023 | 387,173 | 4,664,843 | - | 1.1 | 422,019 | Class A Common Stock |
| Dorman Products Inc | Scott Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.26 per share. | 01 Apr 2023 | 306 | 9,849 (0%) | 0% | 86.3 | 26,396 | Common Stock |
| Dorman Products Inc | Scott Leff | SVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 2,134 | 2,134 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Scott Leff | SVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 842 | 10,155 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Scott Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 02 Mar 2023 | 294 | 9,313 (0%) | 0% | 91.3 | 26,836 | Common Stock |
| Dorman Products Inc | Scott Leff | SVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 2,644 | 10,812 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Scott Leff | SVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.38 per share. | 22 Feb 2023 | 1,205 | 9,607 (0%) | 0% | 93.4 | 112,523 | Common Stock |
| Clover Health Investments ... | Scott J. Leffler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 5,042,016 | 5,052,016 | - | 0 | Class A Common Stock | |
| Sotera Health Co | Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 95,786 | 95,786 | - | - | Stock Options | |
| Sotera Health Co | Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 37,443 | 738,649 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") | |
| Sotera Health Co | Scott J. Leffler | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.54 per share. | 20 Nov 2021 | 3,894 | 701,206 | - | 22.5 | 87,771 | Common Stock, $0.01 par value per share ("Common Stock") |
| Sotera Health Co | Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 223,602 | 223,602 | - | - | Stock Options | |
| Sotera Health Co | Scott J. Leffler | CFO and Treasurer | Sale or transfer of securities back to the company at price $ 21.68 per share. | 20 Nov 2020 | 115,326 | 705,100 | - | 21.7 | 2,500,268 | Common Stock |
| Sotera Health Co | Scott J. Leffler | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 52,173 | 820,426 | - | 0 | Common Stock, $0.01 par value per share ("Common Stock") |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges